AI-assisted design of next-generation antibiotics against multidrug-resistant Staphylococcus aureus

Pharmacology and Therapeutics · Published 2026-07-24 · DOI 10.1016/j.pharmthera.2026.109092

Authors (6)

Youle Zheng, Jin Feng, Qinyuan Chang, Junchen Yu, Yadan Zheng, Yanhua Li

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zheng, Y., Feng, J., Chang, Q., et al. (2026). AI-assisted design of next-generation antibiotics against multidrug-resistant Staphylococcus aureus. Pharmacology and Therapeutics. https://doi.org/10.1016/j.pharmthera.2026.109092

Related articles

• How Artificial Intelligence Assists in Overcoming Drug Resistance? · MEDICINAL RESEARCH REVIEWS · 2025 · Cites or is cited by this article
• Harnessing artificial intelligence for antimicrobial discovery and optimization · Current Opinion in Microbiology · 2026 · Cites or is cited by this article
• Harnessing artificial intelligence to advance CRISPR-based genome editing technologies · Nature Reviews Genetics · 2025 · Cites or is cited by this article
• The aftermath of alcohol misuse: Linking cellular damage, suboptimal micronutrient nutrition, and organ dysfunction · Pharmacology and Therapeutics · 2026 · Same journal
• A dive into the untapped potential of marine compounds in counteracting neurodegeneration · Pharmacology and Therapeutics · 2026 · Same journal
• Mathematical modeling of T cell exhaustion in the tumor microenvironment · Pharmacology and Therapeutics · 2026 · Same journal
• C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy · Pharmacology and Therapeutics · 2026 · Same journal
• Circular RNA serves as an upstream regulator of the miRNA//ABCC1 axis in human cancers · Pharmacology and Therapeutics · 2026 · Same journal
• Clinical relevance of per-particle atherogenicity of triglyceride-rich lipoproteins, Lp(a) and LDL for cardiovascular risk · Pharmacology and Therapeutics · 2026 · Same journal
• Therapeutic potential of targeting novel signaling pathways in regulating chronic inflammation in obstructive lung disorders · Pharmacology and Therapeutics · 2026 · Same journal